APO Research
Talk to an analyst

APO RESEARCH · REPORT

NeuN Antibody

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global NeuN Antibody Market Analysis and Forecast 2026-2032

19 December 2025190 pages

Choose your research edition.

Industry ResearchNeuN Antibody Industry Research Report 2026131 pages · $2,950 USDIndustry Growth & TrendsGlobal NeuN Antibody Industry Growth and Trends Forecast to 2032110 pages · $3,450 USDMarket StructureGlobal NeuN Antibody Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal NeuN Antibody Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal NeuN Antibody Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global NeuN Antibody market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for NeuN Antibody is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for NeuN Antibody is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for NeuN Antibody is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for NeuN Antibody is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of NeuN Antibody include Thermo Fisher Scientific, Merck, Boster Biological Technology, United States Biological, Synaptic, Proteintech, NSJ Bioreagents, Miltenyi Biotec and HUABIO, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for NeuN Antibody, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of NeuN Antibody, also provides the revenue of main regions and countries. Of the upcoming market potential for NeuN Antibody, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the NeuN Antibody revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global NeuN Antibody market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for NeuN Antibody revenue, projected growth trends, production technology, application and end-user industry.

NeuN Antibody Segment by Company

Thermo Fisher Scientific

Merck

Boster Biological Technology

United States Biological

Synaptic

Proteintech

NSJ Bioreagents

Miltenyi Biotec

HUABIO

GeneTex

FineTest

Cell Signaling Technology

Bioss

BioLegend

Abcam

NeuN Antibody Segment by Type

Polyclonal

Monoclonal

NeuN Antibody Segment by Application

Western Blot

Immunocytochemistry

Immunofluorescence

Immunohistochemistry

Others

NeuN Antibody Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global NeuN Antibody market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of NeuN Antibody and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of NeuN Antibody.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of NeuN Antibody in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of NeuN Antibody company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, NeuN Antibody revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global NeuN Antibody Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Polyclonal Major Player Table 3. Monoclonal Major Player Table 4. Global NeuN Antibody Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Western Blot Major Player Table 6. Immunocytochemistry Major Player Table 7. Immunofluorescence Major Player Table 8. Immunohistochemistry Major Player Table 9. Others Major Player Table 10. NeuN Antibody Industry Trends Table 11. NeuN Antibody Industry Drivers Table 12. NeuN Antibody Industry Opportunities and Challenges Table 13. NeuN Antibody Industry Restraints Table 14. Global NeuN Antibody Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 15. Global NeuN Antibody Market Size by Region (2021-2026) & (US$ Million) Table 16. Global NeuN Antibody Market Share by Region (2021-2026) Table 17. Global NeuN Antibody Market Size by Region (2027-2032) & (US$ Million) Table 18. Global NeuN Antibody Market Share by Region (2027-2032) Table 19. Global NeuN Antibody Revenue by Players (US$ Million) & (2021-2026) Table 20. Global NeuN Antibody Revenue Market Share by Players (2021-2026) Table 21. Global NeuN Antibody Key Players Ranking, 2024 VS 2025 VS 2026 Table 22. Global NeuN Antibody Key Players Headquarters & Area Served Table 23. Global NeuN Antibody Players, Product Type & Application Table 24. Global NeuN Antibody Players Establishment Date Table 25. Global Players Market Concentration Ratio (CR5 and HHI) Table 26. Global NeuN Antibody by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 27. Global NeuN Antibody Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global NeuN Antibody Revenue by Type (2021-2026) & (US$ Million) Table 29. Global NeuN Antibody Revenue by Type (2027-2032) & (US$ Million) Table 30. Global NeuN Antibody Revenue Market Share by Type (2021-2026) Table 31. Global NeuN Antibody Revenue Market Share by Type (2027-2032) Table 32. Global NeuN Antibody Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global NeuN Antibody Revenue by Application (2021-2026) & (US$ Million) Table 34. Global NeuN Antibody Revenue by Application (2027-2032) & (US$ Million) Table 35. Global NeuN Antibody Revenue Market Share by Application (2021-2026) Table 36. Global NeuN Antibody Revenue Market Share by Application (2027-2032) Table 37. Thermo Fisher Scientific Company Information Table 38. Thermo Fisher Scientific Business Overview Table 39. Thermo Fisher Scientific NeuN Antibody Revenue and Gross Margin (US$ Million) & (2021-2026) Table 40. Thermo Fisher Scientific NeuN Antibody Product Portfolio Table 41. Thermo Fisher Scientific Recent Development Table 42. Merck Company Information Table 43. Merck Business Overview Table 44. Merck NeuN Antibody Revenue and Gross Margin (US$ Million) & (2021-2026) Table 45. Merck NeuN Antibody Product Portfolio Table 46. Merck Recent Development Table 47. Boster Biological Technology Company Information Table 48. Boster Biological Technology Business Overview Table 49. Boster Biological Technology NeuN Antibody Revenue and Gross Margin (US$ Million) & (2021-2026) Table 50. Boster Biological Technology NeuN Antibody Product Portfolio Table 51. Boster Biological Technology Recent Development Table 52. United States Biological Company Information Table 53. United States Biological Business Overview Table 54. United States Biological NeuN Antibody Revenue and Gross Margin (US$ Million) & (2021-2026) Table 55. United States Biological NeuN Antibody Product Portfolio Table 56. United States Biological Recent Development Table 57. Synaptic Company Information Table 58. Synaptic Business Overview Table 59. Synaptic NeuN Antibody Revenue and Gross Margin (US$ Million) & (2021-2026) Table 60. Synaptic NeuN Antibody Product Portfolio Table 61. Synaptic Recent Development Table 62. Proteintech Company Information Table 63. Proteintech Business Overview Table 64. Proteintech NeuN Antibody Revenue and Gross Margin (US$ Million) & (2021-2026) Table 65. Proteintech NeuN Antibody Product Portfolio Table 66. Proteintech Recent Development Table 67. NSJ Bioreagents Company Information Table 68. NSJ Bioreagents Business Overview Table 69. NSJ Bioreagents NeuN Antibody Revenue and Gross Margin (US$ Million) & (2021-2026) Table 70. NSJ Bioreagents NeuN Antibody Product Portfolio Table 71. NSJ Bioreagents Recent Development Table 72. Miltenyi Biotec Company Information Table 73. Miltenyi Biotec Business Overview Table 74. Miltenyi Biotec NeuN Antibody Revenue and Gross Margin (US$ Million) & (2021-2026) Table 75. Miltenyi Biotec NeuN Antibody Product Portfolio Table 76. Miltenyi Biotec Recent Development Table 77. HUABIO Company Information Table 78. HUABIO Business Overview Table 79. HUABIO NeuN Antibody Revenue and Gross Margin (US$ Million) & (2021-2026) Table 80. HUABIO NeuN Antibody Product Portfolio Table 81. HUABIO Recent Development Table 82. GeneTex Company Information Table 83. GeneTex Business Overview Table 84. GeneTex NeuN Antibody Revenue and Gross Margin (US$ Million) & (2021-2026) Table 85. GeneTex NeuN Antibody Product Portfolio Table 86. GeneTex Recent Development Table 87. FineTest Company Information Table 88. FineTest Business Overview Table 89. FineTest NeuN Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. FineTest NeuN Antibody Product Portfolio Table 91. FineTest Recent Development Table 92. Cell Signaling Technology Company Information Table 93. Cell Signaling Technology Business Overview Table 94. Cell Signaling Technology NeuN Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Cell Signaling Technology NeuN Antibody Product Portfolio Table 96. Cell Signaling Technology Recent Development Table 97. Bioss Company Information Table 98. Bioss Business Overview Table 99. Bioss NeuN Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. Bioss NeuN Antibody Product Portfolio Table 101. Bioss Recent Development Table 102. BioLegend Company Information Table 103. BioLegend Business Overview Table 104. BioLegend NeuN Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. BioLegend NeuN Antibody Product Portfolio Table 106. BioLegend Recent Development Table 107. Abcam Company Information Table 108. Abcam Business Overview Table 109. Abcam NeuN Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. Abcam NeuN Antibody Product Portfolio Table 111. Abcam Recent Development Table 112. North America NeuN Antibody Revenue by Type (2021-2026) & (US$ Million) Table 113. North America NeuN Antibody Revenue by Type (2027-2032) & (US$ Million) Table 114. North America NeuN Antibody Revenue by Application (2021-2026) & (US$ Million) Table 115. North America NeuN Antibody Revenue by Application (2027-2032) & (US$ Million) Table 116. North America NeuN Antibody Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 117. North America NeuN Antibody Revenue by Country (2021-2026) & (US$ Million) Table 118. North America NeuN Antibody Revenue by Country (US$ Million) & (2027-2032) Table 119. Europe NeuN Antibody Revenue by Type (2021-2026) & (US$ Million) Table 120. Europe NeuN Antibody Revenue by Type (2027-2032) & (US$ Million) Table 121. Europe NeuN Antibody Revenue by Application (2021-2026) & (US$ Million) Table 122. Europe NeuN Antibody Revenue by Application (2027-2032) & (US$ Million) Table 123. Europe NeuN Antibody Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 124. Europe NeuN Antibody Revenue by Country (2021-2026) & (US$ Million) Table 125. Europe NeuN Antibody Revenue by Country (US$ Million) & (2027-2032) Table 126. China NeuN Antibody Revenue by Type (2021-2026) & (US$ Million) Table 127. China NeuN Antibody Revenue by Type (2027-2032) & (US$ Million) Table 128. China NeuN Antibody Revenue by Application (2021-2026) & (US$ Million) Table 129. China NeuN Antibody Revenue by Application (2027-2032) & (US$ Million) Table 130. Asia NeuN Antibody Revenue by Type (2021-2026) & (US$ Million) Table 131. Asia NeuN Antibody Revenue by Type (2027-2032) & (US$ Million) Table 132. Asia NeuN Antibody Revenue by Application (2021-2026) & (US$ Million) Table 133. Asia NeuN Antibody Revenue by Application (2027-2032) & (US$ Million) Table 134. Asia NeuN Antibody Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 135. Asia NeuN Antibody Revenue by Region (US$ Million) & (2021-2026) Table 136. Asia NeuN Antibody Revenue by Region (US$ Million) & (2027-2032) Table 137. SAMEA NeuN Antibody Revenue by Type (2021-2026) & (US$ Million) Table 138. SAMEA NeuN Antibody Revenue by Type (2027-2032) & (US$ Million) Table 139. SAMEA NeuN Antibody Revenue by Application (2021-2026) & (US$ Million) Table 140. SAMEA NeuN Antibody Revenue by Application (2027-2032) & (US$ Million) Table 141. SAMEA NeuN Antibody Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 142. SAMEA NeuN Antibody Revenue by Country (2021-2026) & (US$ Million) Table 143. SAMEA NeuN Antibody Revenue by Country (US$ Million) & (2027-2032) Table 144. Research Programs/Design for This Report Table 145. Authors List of This Report Table 146. Secondary Sources Table 147. Primary Sources List of Figures Figure 1. NeuN Antibody Image Figure 2. Global NeuN Antibody Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global NeuN Antibody Market Size Share 2021 VS 2025 VS 2032 Figure 4. Polyclonal Image Figure 5. Monoclonal Image Figure 6. Global NeuN Antibody Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global NeuN Antibody Market Size Share 2021 VS 2025 VS 2032 Figure 8. Western Blot Image Figure 9. Immunocytochemistry Image Figure 10. Immunofluorescence Image Figure 11. Immunohistochemistry Image Figure 12. Others Image Figure 13. Global NeuN Antibody Market Size (US$ Million) & (2021-2032) Figure 14. Global NeuN Antibody Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global NeuN Antibody Market Share by Region: 2021 VS 2025 VS 2032 Figure 16. Global NeuN Antibody Players Revenue Share Top 10 and Top 5 in 2025 Figure 17. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global NeuN Antibody Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global NeuN Antibody Revenue Market Share 2021 VS 2025 VS 2032 Figure 20. Global NeuN Antibody Revenue Market Share by Type (2021-2032) Figure 21. Global NeuN Antibody Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global NeuN Antibody Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 23. Global NeuN Antibody Revenue Market Share by Application (2021-2032) Figure 24. North America NeuN Antibody Revenue YoY Growth (2021-2032) & (US$ Million) Figure 25. North America NeuN Antibody Revenue Share by Type (2021-2032) Figure 26. North America NeuN Antibody Revenue Share by Application (2021-2032) Figure 27. North America NeuN Antibody Revenue Share by Country (2021-2032) Figure 28. United States NeuN Antibody Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Canada NeuN Antibody Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Mexico NeuN Antibody Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Europe NeuN Antibody Revenue YoY Growth (2021-2032) & (US$ Million) Figure 32. Europe NeuN Antibody Revenue Share by Type (2021-2032) Figure 33. Europe NeuN Antibody Revenue Share by Application (2021-2032) Figure 34. Europe NeuN Antibody Revenue Share by Country (2021-2032) Figure 35. Germany NeuN Antibody Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. France NeuN Antibody Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. U.K. NeuN Antibody Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Italy NeuN Antibody Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Spain NeuN Antibody Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Russia NeuN Antibody Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Netherlands NeuN Antibody Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Nordic Countries NeuN Antibody Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. China NeuN Antibody Revenue YoY Growth (2021-2032) & (US$ Million) Figure 44. China NeuN Antibody Revenue Share by Type (2021-2032) Figure 45. China NeuN Antibody Revenue Share by Application (2021-2032) Figure 46. Asia NeuN Antibody Revenue YoY Growth (2021-2032) & (US$ Million) Figure 47. Asia NeuN Antibody Revenue Share by Type (2021-2032) Figure 48. Asia NeuN Antibody Revenue Share by Application (2021-2032) Figure 49. Asia NeuN Antibody Revenue Share by Region (2021-2032) Figure 50. Japan NeuN Antibody Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. South Korea NeuN Antibody Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. India NeuN Antibody Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Australia NeuN Antibody Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Taiwan NeuN Antibody Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Southeast Asia NeuN Antibody Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. SAMEA NeuN Antibody Revenue YoY Growth (2021-2032) & (US$ Million) Figure 57. SAMEA NeuN Antibody Revenue Share by Type (2021-2032) Figure 58. SAMEA NeuN Antibody Revenue Share by Application (2021-2032) Figure 59. SAMEA NeuN Antibody Revenue Share by Country (2021-2032) Figure 60. Brazil NeuN Antibody Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Argentina NeuN Antibody Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Chile NeuN Antibody Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Colombia NeuN Antibody Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Peru NeuN Antibody Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Saudi Arabia NeuN Antibody Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Israel NeuN Antibody Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. UAE NeuN Antibody Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Turkey NeuN Antibody Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Iran NeuN Antibody Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Egypt NeuN Antibody Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Polyclonal
  • Monoclonal
Applications
  • Western Blot
  • Immunocytochemistry
  • Immunofluorescence
  • Immunohistochemistry
  • Others
Companies covered
  • Thermo Fisher Scientific
  • Merck
  • Boster Biological Technology
  • United States Biological
  • Synaptic
  • Proteintech
  • NSJ Bioreagents
  • Miltenyi Biotec
  • HUABIO
  • GeneTex
  • FineTest
  • Cell Signaling Technology
  • Bioss
  • BioLegend
  • Abcam

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 NeuN Antibody Market by Type
  3. 1.2.1 Global NeuN Antibody Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Polyclonal
  5. 1.2.3 Monoclonal
  6. 1.3 NeuN Antibody Market by Application
  7. 1.3.1 Global NeuN Antibody Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Western Blot
  9. 1.3.3 Immunocytochemistry
  10. 1.3.4 Immunofluorescence
  11. 1.3.5 Immunohistochemistry
  12. 1.3.6 Others
  13. 1.4 Assumptions and Limitations
  14. 1.5 Study Goals and Objectives
2 NeuN Antibody Market Dynamics
  1. 2.1 NeuN Antibody Industry Trends
  2. 2.2 NeuN Antibody Industry Drivers
  3. 2.3 NeuN Antibody Industry Opportunities and Challenges
  4. 2.4 NeuN Antibody Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global NeuN Antibody Market Perspective (2021-2032)
  2. 3.2 Global NeuN Antibody Growth Trends by Region
  3. 3.2.1 Global NeuN Antibody Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global NeuN Antibody Market Size by Region (2021-2026)
  5. 3.2.3 Global NeuN Antibody Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global NeuN Antibody Revenue by Players
  2. 4.1.1 Global NeuN Antibody Revenue by Players (2021-2026)
  3. 4.1.2 Global NeuN Antibody Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global NeuN Antibody Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global NeuN Antibody Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global NeuN Antibody Key Players Headquarters & Area Served
  7. 4.4 Global NeuN Antibody Players, Product Type & Application
  8. 4.5 Global NeuN Antibody Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global NeuN Antibody Market CR5 and HHI
  11. 4.6.3 2025 NeuN Antibody Tier 1, Tier 2, and Tier 3
5 NeuN Antibody Market Size by Type
  1. 5.1 Global NeuN Antibody Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global NeuN Antibody Revenue by Type (2021-2032)
  3. 5.3 Global NeuN Antibody Revenue Market Share by Type (2021-2032)
6 NeuN Antibody Market Size by Application
  1. 6.1 Global NeuN Antibody Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global NeuN Antibody Revenue by Application (2021-2032)
  3. 6.3 Global NeuN Antibody Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Thermo Fisher Scientific
  2. 7.1.1 Thermo Fisher Scientific Company Information
  3. 7.1.2 Thermo Fisher Scientific Business Overview
  4. 7.1.3 Thermo Fisher Scientific NeuN Antibody Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Thermo Fisher Scientific NeuN Antibody Product Portfolio
  6. 7.1.5 Thermo Fisher Scientific Recent Developments
  7. 7.2 Merck
  8. 7.2.1 Merck Company Information
  9. 7.2.2 Merck Business Overview
  10. 7.2.3 Merck NeuN Antibody Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Merck NeuN Antibody Product Portfolio
  12. 7.2.5 Merck Recent Developments
  13. 7.3 Boster Biological Technology
  14. 7.3.1 Boster Biological Technology Company Information
  15. 7.3.2 Boster Biological Technology Business Overview
  16. 7.3.3 Boster Biological Technology NeuN Antibody Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Boster Biological Technology NeuN Antibody Product Portfolio
  18. 7.3.5 Boster Biological Technology Recent Developments
  19. 7.4 United States Biological
  20. 7.4.1 United States Biological Company Information
  21. 7.4.2 United States Biological Business Overview
  22. 7.4.3 United States Biological NeuN Antibody Revenue and Gross Margin (2021-2026)
  23. 7.4.4 United States Biological NeuN Antibody Product Portfolio
  24. 7.4.5 United States Biological Recent Developments
  25. 7.5 Synaptic
  26. 7.5.1 Synaptic Company Information
  27. 7.5.2 Synaptic Business Overview
  28. 7.5.3 Synaptic NeuN Antibody Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Synaptic NeuN Antibody Product Portfolio
  30. 7.5.5 Synaptic Recent Developments
  31. 7.6 Proteintech
  32. 7.6.1 Proteintech Company Information
  33. 7.6.2 Proteintech Business Overview
  34. 7.6.3 Proteintech NeuN Antibody Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Proteintech NeuN Antibody Product Portfolio
  36. 7.6.5 Proteintech Recent Developments
  37. 7.7 NSJ Bioreagents
  38. 7.7.1 NSJ Bioreagents Company Information
  39. 7.7.2 NSJ Bioreagents Business Overview
  40. 7.7.3 NSJ Bioreagents NeuN Antibody Revenue and Gross Margin (2021-2026)
  41. 7.7.4 NSJ Bioreagents NeuN Antibody Product Portfolio
  42. 7.7.5 NSJ Bioreagents Recent Developments
  43. 7.8 Miltenyi Biotec
  44. 7.8.1 Miltenyi Biotec Company Information
  45. 7.8.2 Miltenyi Biotec Business Overview
  46. 7.8.3 Miltenyi Biotec NeuN Antibody Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Miltenyi Biotec NeuN Antibody Product Portfolio
  48. 7.8.5 Miltenyi Biotec Recent Developments
  49. 7.9 HUABIO
  50. 7.9.1 HUABIO Company Information
  51. 7.9.2 HUABIO Business Overview
  52. 7.9.3 HUABIO NeuN Antibody Revenue and Gross Margin (2021-2026)
  53. 7.9.4 HUABIO NeuN Antibody Product Portfolio
  54. 7.9.5 HUABIO Recent Developments
  55. 7.10 GeneTex
  56. 7.10.1 GeneTex Company Information
  57. 7.10.2 GeneTex Business Overview
  58. 7.10.3 GeneTex NeuN Antibody Revenue and Gross Margin (2021-2026)
  59. 7.10.4 GeneTex NeuN Antibody Product Portfolio
  60. 7.10.5 GeneTex Recent Developments
  61. 7.11 FineTest
  62. 7.11.1 FineTest Company Information
  63. 7.11.2 FineTest Business Overview
  64. 7.11.3 FineTest NeuN Antibody Revenue and Gross Margin (2021-2026)
  65. 7.11.4 FineTest NeuN Antibody Product Portfolio
  66. 7.11.5 FineTest Recent Developments
  67. 7.12 Cell Signaling Technology
  68. 7.12.1 Cell Signaling Technology Company Information
  69. 7.12.2 Cell Signaling Technology Business Overview
  70. 7.12.3 Cell Signaling Technology NeuN Antibody Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Cell Signaling Technology NeuN Antibody Product Portfolio
  72. 7.12.5 Cell Signaling Technology Recent Developments
  73. 7.13 Bioss
  74. 7.13.1 Bioss Company Information
  75. 7.13.2 Bioss Business Overview
  76. 7.13.3 Bioss NeuN Antibody Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Bioss NeuN Antibody Product Portfolio
  78. 7.13.5 Bioss Recent Developments
  79. 7.14 BioLegend
  80. 7.14.1 BioLegend Company Information
  81. 7.14.2 BioLegend Business Overview
  82. 7.14.3 BioLegend NeuN Antibody Revenue and Gross Margin (2021-2026)
  83. 7.14.4 BioLegend NeuN Antibody Product Portfolio
  84. 7.14.5 BioLegend Recent Developments
  85. 7.15 Abcam
  86. 7.15.1 Abcam Company Information
  87. 7.15.2 Abcam Business Overview
  88. 7.15.3 Abcam NeuN Antibody Revenue and Gross Margin (2021-2026)
  89. 7.15.4 Abcam NeuN Antibody Product Portfolio
  90. 7.15.5 Abcam Recent Developments
8 North America
  1. 8.1 North America NeuN Antibody Revenue (2021-2032)
  2. 8.2 North America NeuN Antibody Revenue by Type (2021-2032)
  3. 8.2.1 North America NeuN Antibody Revenue by Type (2021-2026)
  4. 8.2.2 North America NeuN Antibody Revenue by Type (2027-2032)
  5. 8.3 North America NeuN Antibody Revenue Share by Type (2021-2032)
  6. 8.4 North America NeuN Antibody Revenue by Application (2021-2032)
  7. 8.4.1 North America NeuN Antibody Revenue by Application (2021-2026)
  8. 8.4.2 North America NeuN Antibody Revenue by Application (2027-2032)
  9. 8.5 North America NeuN Antibody Revenue Share by Application (2021-2032)
  10. 8.6 North America NeuN Antibody Revenue by Country
  11. 8.6.1 North America NeuN Antibody Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America NeuN Antibody Revenue by Country (2021-2026)
  13. 8.6.3 North America NeuN Antibody Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
9 Europe
  1. 9.1 Europe NeuN Antibody Revenue (2021-2032)
  2. 9.2 Europe NeuN Antibody Revenue by Type (2021-2032)
  3. 9.2.1 Europe NeuN Antibody Revenue by Type (2021-2026)
  4. 9.2.2 Europe NeuN Antibody Revenue by Type (2027-2032)
  5. 9.3 Europe NeuN Antibody Revenue Share by Type (2021-2032)
  6. 9.4 Europe NeuN Antibody Revenue by Application (2021-2032)
  7. 9.4.1 Europe NeuN Antibody Revenue by Application (2021-2026)
  8. 9.4.2 Europe NeuN Antibody Revenue by Application (2027-2032)
  9. 9.5 Europe NeuN Antibody Revenue Share by Application (2021-2032)
  10. 9.6 Europe NeuN Antibody Revenue by Country
  11. 9.6.1 Europe NeuN Antibody Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe NeuN Antibody Revenue by Country (2021-2026)
  13. 9.6.3 Europe NeuN Antibody Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Netherlands
10 China
  1. 10.1 China NeuN Antibody Revenue (2021-2032)
  2. 10.2 China NeuN Antibody Revenue by Type (2021-2032)
  3. 10.2.1 China NeuN Antibody Revenue by Type (2021-2026)
  4. 10.2.2 China NeuN Antibody Revenue by Type (2027-2032)
  5. 10.3 China NeuN Antibody Revenue Share by Type (2021-2032)
  6. 10.4 China NeuN Antibody Revenue by Application (2021-2032)
  7. 10.4.1 China NeuN Antibody Revenue by Application (2021-2026)
  8. 10.4.2 China NeuN Antibody Revenue by Application (2027-2032)
  9. 10.5 China NeuN Antibody Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia NeuN Antibody Revenue (2021-2032)
  2. 11.2 Asia NeuN Antibody Revenue by Type (2021-2032)
  3. 11.2.1 Asia NeuN Antibody Revenue by Type (2021-2026)
  4. 11.2.2 Asia NeuN Antibody Revenue by Type (2027-2032)
  5. 11.3 Asia NeuN Antibody Revenue Share by Type (2021-2032)
  6. 11.4 Asia NeuN Antibody Revenue by Application (2021-2032)
  7. 11.4.1 Asia NeuN Antibody Revenue by Application (2021-2026)
  8. 11.4.2 Asia NeuN Antibody Revenue by Application (2027-2032)
  9. 11.5 Asia NeuN Antibody Revenue Share by Application (2021-2032)
  10. 11.6 Asia NeuN Antibody Revenue by Country
  11. 11.6.1 Asia NeuN Antibody Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia NeuN Antibody Revenue by Country (2021-2026)
  13. 11.6.3 Asia NeuN Antibody Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA NeuN Antibody Revenue (2021-2032)
  2. 12.2 SAMEA NeuN Antibody Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA NeuN Antibody Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA NeuN Antibody Revenue by Type (2027-2032)
  5. 12.3 SAMEA NeuN Antibody Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA NeuN Antibody Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA NeuN Antibody Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA NeuN Antibody Revenue by Application (2027-2032)
  9. 12.5 SAMEA NeuN Antibody Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA NeuN Antibody Revenue by Country
  11. 12.6.1 SAMEA NeuN Antibody Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA NeuN Antibody Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA NeuN Antibody Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst